MUMBAI, May 16 (Reuters) - India's Glenmark Pharmaceuticals said on Wednesday it had approval from the U.S. Food and Drug Administration to sell pravastatin sodium oral tablets, which it said was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results